Newpace

Company Overview

Snapshot

Founded in October 2012 by Avi Broder, Newpace operates with 1–10 employees. The company has raised $2 million across two funding rounds, with investments from Net Capital Ventures and BioStar Capital. In June 2017, Newpace secured a grant from EU Horizon 2020.

Business overview

Newpace is a Health Tech & Life Sciences company focused on developing a flexible and subcutaneous implantable cardioverter defibrillator (ICD). Its core technology involves a leadless device with a wireless rechargeable battery and Bluetooth communication, designed to be implanted subcutaneously without the need for fluoroscopy. The company's product, the ISSD, aims to provide a less invasive solution for cardiac rhythm management, serving patients and healthcare providers in markets such as Israel, the United States, and China.

Strategic signal

In June 2021, Newpace partnered with Powermat Technologies, a leader in wireless power, to develop advanced wireless charging technology for its life-saving devices. This collaboration signals a strategic move to enhance the usability and patient experience of its implantable cardioverter defibrillator by integrating cutting-edge wireless charging capabilities, potentially reducing maintenance burdens and improving device longevity.

Company Intelligence Q&A

What is Newpace's primary product?

Newpace's primary product is a flexible and subcutaneous implantable cardioverter defibrillator (ICD) that operates without leads within the heart. This device features a wireless rechargeable battery and Bluetooth communication for monitoring.

When was Newpace founded and by whom?

Newpace was founded in October 2012 by Avi Broder.

What significant partnership did Newpace announce in June 2021?

In June 2021, Newpace selected Powermat Technologies to develop advanced wireless charging technology for its innovative life-saving devices, aiming to enhance the functionality of its subcutaneous ICD.

What type of funding did Newpace receive in June 2017?

In June 2017, Newpace secured a grant from EU Horizon 2020.

Which investors participated in Newpace's August 2015 funding round?

In August 2015, Newpace received funding from Net Capital Ventures and BioStar Capital.